Edition:
India

OncoMed Pharmaceuticals Inc (OMED.OQ)

OMED.OQ on NASDAQ Stock Exchange Global Select Market

2.26USD
24 Sep 2018
Change (% chg)

-- (--)
Prev Close
$2.26
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
13,082
52-wk High
$5.55
52-wk Low
$1.75

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.20 December 26 Sep 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 2 2 2
(2) OUTPERFORM 0 0 0 0
(3) HOLD 1 1 1 2
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.67 1.67 1.67 2.00

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 3 7.38 9.43 6.20 5.61
Quarter Ending Dec-18 3 7.16 9.27 6.00 5.61
Year Ending Dec-18 3 29.24 33.41 27.10 31.03
Year Ending Dec-19 3 25.69 27.00 25.00 44.20
Earnings (per share)
Quarter Ending Sep-18 3 -0.20 -0.10 -0.37 -0.39
Quarter Ending Dec-18 3 -0.19 -0.09 -0.36 -0.38
Year Ending Dec-18 3 -0.73 -0.44 -1.25 -1.51
Year Ending Dec-19 3 -0.85 -0.49 -1.50 -0.92

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-18 7.06 6.87 0.19 2.69
Quarter Ending Mar-18 6.76 7.85 1.09 16.11
Quarter Ending Dec-17 5.20 20.64 15.44 296.82
Quarter Ending Sep-17 5.12 5.11 0.02 0.30
Quarter Ending Jun-17 4.85 6.20 1.34 27.68

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 7.38 7.38 7.38 7.21 5.61
Quarter Ending Dec-18 7.16 7.16 7.16 7.16 5.61
Year Ending Dec-18 29.24 29.24 29.24 29.24 31.03
Year Ending Dec-19 25.69 26.69 26.69 25.65 44.20

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-18 0 0 0 0
Quarter Ending Dec-18 0 0 0 0
Year Ending Dec-18 0 0 0 0
Year Ending Dec-19 0 1 0 1
Earnings